Loading...

WP4 LOI accepted by the FDA!

2022-03-23T15:40:21+00:00April 8th, 2020|Clinical Studies|

The TransBioLine WP4 (Biomarkers of vascular injury) Letter of Intent was accepted by the FDA on February 2020 and the team is in preparation to discuss the FDA recommendations to [...]